This is publicly available on https://www.takeda.com Takeda has also developed a new Enhanced Patient Access Global Policy, that defines a company-wide approach to providing access to Takeda’s investigational or marketed products outside of standard development (e.g. clinical trials) or commercial channels (e.g. healthcare systems).